Provided by Tiger Trade Technology Pte. Ltd.

INNOCARE

14.400
-0.510-3.42%
Volume:11.37M
Turnover:167.31M
Market Cap:25.44B
PE:32.48
High:15.420
Open:15.000
Low:14.330
Close:14.910
52wk High:20.180
52wk Low:9.650
Shares:1.77B
HK Float Shares:1.49B
Volume Ratio:1.35
T/O Rate:0.76%
Dividend:- -
Dividend Rate:- -
EPS(LYR):0.443
ROE:12.77%
ROA:4.45%
PB:2.84
PE(LYR):32.48
PS:7.84

Loading ...

Movement Alert|InnoCare Pharma Rises 5.09% in Regular Trading, Biotech Sector Rallies as CDH17 ADC Clinical Data Published

Market Focus
·
Jul 15

InnoCare Pharma (SEHK:9969) Is Up 6.6% After First CDH17 ADC Enters Human Trials

Simply Wall St.
·
Jul 14

Is InnoCare Pharma (SEHK:9969) Undervalued On Its Breakthrough Lupus Trial Results?

Simply Wall St.
·
Jul 11

Movement Alert|InnoCare Pharma Rises 5.07% in Regular Trading, HK Innovative Drug Sector Rallies as ADC Pipeline Advances

Market Focus
·
Jul 10

Innocare Pharma Shares Advance with Robust Quarterly Earnings Growth

Deep News
·
Jul 09

Hong Kong Market Closes Higher, Healthcare and Tech Stocks Lead Gains While AI Hardware Sector Plunges

Stock News
·
Jul 06

Biopharma Stocks Continue to Rally in Early Trading Session

Deep News
·
Jul 06

Innovative Drug Sector Maintains Upward Momentum on Favorable Regulatory Developments and Accelerating Internationalization

Stock News
·
Jul 06

Innocare's Stock Surges Over 9% as First Patient Dosed with Novel In-house Developed CDH17-Targeting ADC Drug

Deep News
·
Jul 06

Movement Alert|InnoCare Pharma Rises 6.65% in Regular Trading, Self-Developed ADC Drug ICP-B208 Completes First Patient Dosing

Market Focus
·
Jul 06

Hong Kong Innovative Drug Stocks Jump With HAIXI PHARMA and INNOCARE up 7%; KEYMED up 5%, REMEGEN up 4%

Tiger Newspress
·
Jul 06

Innocare Shares Surge Over 8% Following First Patient Dosing of Novel In-House ADC Drug

Stock News
·
Jul 06

InnoCare issues 1.91 million RSUs under 2023 Share Award Scheme, equal to 0.11% of share capital

Bulletin Express
·
Jun 30

Innocare Pharma Issues 2.42 Million New Shares Under 2024 Equity Incentive Plan

Stock News
·
Jun 26

Extensive Orelabrutinib Data Across Regions Might Change The Case For Investing In InnoCare Pharma (SEHK:9969)

Simply Wall St.
·
Jun 22

InnoCare Pharma (SEHK:9969) Stock Could Be 45% Undervalued After EHA 2026 Data

Simply Wall St.
·
Jun 21

Innocare Pharma Shares Surge Over 5% on Positive Phase III Data for Tafasitamab Combo in Frontline DLBCL

Stock News
·
Jun 18

INNOCARE Issues 8 Million Restricted Shares Under Incentive Plan

Stock News
·
Jun 16

InnoCare issues 8.00 million restricted shares (0.45% stake) in first tranche of 2026 RMB Share Incentive Scheme

Bulletin Express
·
Jun 16

InnoCare Pharma: Shareholders Overwhelmingly Approve All 24 Resolutions at 2026 AGM

Bulletin Express
·
Jun 16